STOCK TITAN

[Form 4] Elevation Oncology, Inc. Common stock Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Shimmick Corp. (SHIM) – Form 144 filing discloses that insider Mitchell B. Goldsteen plans to sell up to 3,900 common shares through TD Securities on or about 24 Jul 2025. At the most recent market price used in the filing, the sale would raise roughly $8.1 k. The proposed shares represent less than 0.01 % of the company’s 34.36 m shares outstanding.

The notice also lists an extensive series of prior open-market sales by Goldsteen during the past three months. Adding the individual transactions shown, the insider has already disposed of ≈252 k shares, generating cumulative gross proceeds of several hundred thousand dollars. The new 3,900-share lot suggests continued selling momentum.

No financial performance data, corporate events or explanatory remarks accompany the filing; Form 144 only signals a potential disposition. Investors typically view persistent insider selling—particularly at this scale—as a bearish sentiment indicator, although the absolute percentages remain small relative to total shares outstanding.

Shimmick Corp. (SHIM) – Deposito del Modulo 144 rivela che l'insider Mitchell B. Goldsteen intende vendere fino a 3.900 azioni ordinarie tramite TD Securities intorno al 24 luglio 2025. Al prezzo di mercato più recente indicato nel deposito, la vendita genererebbe circa 8,1 mila dollari. Le azioni proposte rappresentano meno dello 0,01% delle 34,36 milioni di azioni in circolazione della società.

La comunicazione elenca inoltre una lunga serie di vendite precedenti sul mercato aperto effettuate da Goldsteen negli ultimi tre mesi. Sommando le singole transazioni riportate, l'insider ha già ceduto circa 252 mila azioni, ottenendo un ricavo lordo cumulativo di diverse centinaia di migliaia di dollari. Il nuovo lotto di 3.900 azioni indica una continuazione della pressione di vendita.

Nel deposito non sono presenti dati sulle performance finanziarie, eventi societari o commenti esplicativi; il Modulo 144 segnala soltanto una possibile disposizione azionaria. Gli investitori generalmente interpretano una vendita persistente da parte degli insider—specialmente a questo livello—come un segnale di sentiment ribassista, anche se le percentuali assolute rimangono contenute rispetto al totale delle azioni in circolazione.

Shimmick Corp. (SHIM) – Presentación del Formulario 144 revela que el insider Mitchell B. Goldsteen planea vender hasta 3,900 acciones comunes a través de TD Securities alrededor del 24 de julio de 2025. Al precio de mercado más reciente utilizado en la presentación, la venta generaría aproximadamente $8.1 mil. Las acciones propuestas representan menos del 0,01% de las 34.36 millones de acciones en circulación de la empresa.

La notificación también enumera una extensa serie de ventas previas en el mercado abierto realizadas por Goldsteen durante los últimos tres meses. Sumando las transacciones individuales mostradas, el insider ya ha vendido aproximadamente 252 mil acciones, generando ingresos brutos acumulados de varios cientos de miles de dólares. El nuevo lote de 3,900 acciones sugiere un impulso continuo de venta.

No se acompañan datos financieros, eventos corporativos ni comentarios explicativos en la presentación; el Formulario 144 solo indica una posible disposición. Los inversores suelen considerar la venta persistente por parte de insiders—especialmente a esta escala—como un indicador de sentimiento bajista, aunque los porcentajes absolutos siguen siendo pequeños en relación con el total de acciones en circulación.

Shimmick Corp. (SHIM) – Form 144 제출에 따르면 내부자 Mitchell B. Goldsteen가 2025년 7월 24일경 TD Securities를 통해 최대 3,900 보통주를 매도할 계획임을 공개했습니다. 제출서에 사용된 최근 시장 가격 기준으로 이번 매도는 약 8,100달러의 자금을 조달할 것으로 예상됩니다. 제안된 주식 수는 회사의 총 3,436만 주0.01% 미만에 해당합니다.

해당 공지에는 지난 3개월 동안 Goldsteen이 공개 시장에서 진행한 광범위한 매도 내역도 나열되어 있습니다. 개별 거래를 합산하면 내부자는 이미 약 252,000주를 처분해 수십만 달러의 총 매출을 기록했습니다. 이번 3,900주 매도는 매도세가 계속되고 있음을 시사합니다.

재무 실적 데이터, 기업 이벤트 또는 설명은 제출서에 포함되어 있지 않으며, Form 144는 단지 잠재적 처분 가능성을 알리는 신호입니다. 투자자들은 대개 내부자의 지속적인 매도를—특히 이 정도 규모에서는—약세 심리 신호로 해석하지만, 전체 발행 주식 대비 절대 비율은 여전히 작습니다.

Shimmick Corp. (SHIM) – Dépôt du formulaire 144 révèle que l'initié Mitchell B. Goldsteen prévoit de vendre jusqu'à 3 900 actions ordinaires via TD Securities aux alentours du 24 juillet 2025. Au dernier cours de marché utilisé dans le dépôt, cette vente rapporterait environ 8,1 k$. Les actions proposées représentent moins de 0,01 % des 34,36 millions d'actions en circulation de la société.

L'avis liste également une série étendue de ventes précédentes sur le marché libre effectuées par Goldsteen au cours des trois derniers mois. En additionnant les transactions individuelles, l'initié a déjà cédé environ 252 000 actions, générant un produit brut cumulé de plusieurs centaines de milliers de dollars. Le nouveau lot de 3 900 actions suggère une poursuite de la tendance à la vente.

Aucune donnée financière, événement d'entreprise ou commentaire explicatif n'accompagne le dépôt ; le formulaire 144 signale uniquement une possible cession. Les investisseurs considèrent généralement une vente persistante par les initiés — surtout à cette échelle — comme un indicateur de sentiment baissier, bien que les pourcentages absolus restent faibles par rapport au total des actions en circulation.

Shimmick Corp. (SHIM) – Form 144 Einreichung offenbart, dass Insider Mitchell B. Goldsteen plant, bis zu 3.900 Stammaktien über TD Securities etwa am 24. Juli 2025 zu verkaufen. Basierend auf dem zuletzt in der Einreichung verwendeten Marktpreis würde der Verkauf rund 8,1 Tausend US-Dollar einbringen. Die vorgeschlagenen Aktien entsprechen weniger als 0,01 % der insgesamt 34,36 Millionen ausstehenden Aktien des Unternehmens.

Die Mitteilung listet zudem eine umfangreiche Reihe vorheriger Verkäufe durch Goldsteen am offenen Markt in den letzten drei Monaten auf. Addiert man die einzelnen Transaktionen, hat der Insider bereits etwa 252.000 Aktien veräußert und dabei kumulierte Bruttoerlöse in mehreren hunderttausend Dollar erzielt. Die neue Tranche von 3.900 Aktien deutet auf eine Fortsetzung des Verkaufsdrucks hin.

Finanzielle Leistungsdaten, Unternehmensereignisse oder erläuternde Bemerkungen sind der Einreichung nicht beigefügt; das Form 144 signalisiert lediglich eine potenzielle Veräußerung. Investoren werten anhaltende Insiderverkäufe – insbesondere in diesem Umfang – typischerweise als bärisches Sentiment-Signal, obwohl die absoluten Prozentsätze im Verhältnis zu den ausstehenden Aktien gering bleiben.

Positive
  • None.
Negative
  • Continued insider selling: Goldsteen has sold ≈252 k shares over three months and now files to dispose of another 3,900, potentially signaling weak insider confidence.

Insights

TL;DR – Serial insider disposals; another 3,900 shares queued.

The filing adds a marginal 3,900-share sale to Goldsteen’s already heavy three-month sell program (~252 k shares). While the lot is immaterial to float, sustained insider selling often pressures sentiment and may signal limited near-term confidence. No operational data accompany the notice, so the market reaction will hinge on cumulative selling optics rather than fundamentals.

Shimmick Corp. (SHIM) – Deposito del Modulo 144 rivela che l'insider Mitchell B. Goldsteen intende vendere fino a 3.900 azioni ordinarie tramite TD Securities intorno al 24 luglio 2025. Al prezzo di mercato più recente indicato nel deposito, la vendita genererebbe circa 8,1 mila dollari. Le azioni proposte rappresentano meno dello 0,01% delle 34,36 milioni di azioni in circolazione della società.

La comunicazione elenca inoltre una lunga serie di vendite precedenti sul mercato aperto effettuate da Goldsteen negli ultimi tre mesi. Sommando le singole transazioni riportate, l'insider ha già ceduto circa 252 mila azioni, ottenendo un ricavo lordo cumulativo di diverse centinaia di migliaia di dollari. Il nuovo lotto di 3.900 azioni indica una continuazione della pressione di vendita.

Nel deposito non sono presenti dati sulle performance finanziarie, eventi societari o commenti esplicativi; il Modulo 144 segnala soltanto una possibile disposizione azionaria. Gli investitori generalmente interpretano una vendita persistente da parte degli insider—specialmente a questo livello—come un segnale di sentiment ribassista, anche se le percentuali assolute rimangono contenute rispetto al totale delle azioni in circolazione.

Shimmick Corp. (SHIM) – Presentación del Formulario 144 revela que el insider Mitchell B. Goldsteen planea vender hasta 3,900 acciones comunes a través de TD Securities alrededor del 24 de julio de 2025. Al precio de mercado más reciente utilizado en la presentación, la venta generaría aproximadamente $8.1 mil. Las acciones propuestas representan menos del 0,01% de las 34.36 millones de acciones en circulación de la empresa.

La notificación también enumera una extensa serie de ventas previas en el mercado abierto realizadas por Goldsteen durante los últimos tres meses. Sumando las transacciones individuales mostradas, el insider ya ha vendido aproximadamente 252 mil acciones, generando ingresos brutos acumulados de varios cientos de miles de dólares. El nuevo lote de 3,900 acciones sugiere un impulso continuo de venta.

No se acompañan datos financieros, eventos corporativos ni comentarios explicativos en la presentación; el Formulario 144 solo indica una posible disposición. Los inversores suelen considerar la venta persistente por parte de insiders—especialmente a esta escala—como un indicador de sentimiento bajista, aunque los porcentajes absolutos siguen siendo pequeños en relación con el total de acciones en circulación.

Shimmick Corp. (SHIM) – Form 144 제출에 따르면 내부자 Mitchell B. Goldsteen가 2025년 7월 24일경 TD Securities를 통해 최대 3,900 보통주를 매도할 계획임을 공개했습니다. 제출서에 사용된 최근 시장 가격 기준으로 이번 매도는 약 8,100달러의 자금을 조달할 것으로 예상됩니다. 제안된 주식 수는 회사의 총 3,436만 주0.01% 미만에 해당합니다.

해당 공지에는 지난 3개월 동안 Goldsteen이 공개 시장에서 진행한 광범위한 매도 내역도 나열되어 있습니다. 개별 거래를 합산하면 내부자는 이미 약 252,000주를 처분해 수십만 달러의 총 매출을 기록했습니다. 이번 3,900주 매도는 매도세가 계속되고 있음을 시사합니다.

재무 실적 데이터, 기업 이벤트 또는 설명은 제출서에 포함되어 있지 않으며, Form 144는 단지 잠재적 처분 가능성을 알리는 신호입니다. 투자자들은 대개 내부자의 지속적인 매도를—특히 이 정도 규모에서는—약세 심리 신호로 해석하지만, 전체 발행 주식 대비 절대 비율은 여전히 작습니다.

Shimmick Corp. (SHIM) – Dépôt du formulaire 144 révèle que l'initié Mitchell B. Goldsteen prévoit de vendre jusqu'à 3 900 actions ordinaires via TD Securities aux alentours du 24 juillet 2025. Au dernier cours de marché utilisé dans le dépôt, cette vente rapporterait environ 8,1 k$. Les actions proposées représentent moins de 0,01 % des 34,36 millions d'actions en circulation de la société.

L'avis liste également une série étendue de ventes précédentes sur le marché libre effectuées par Goldsteen au cours des trois derniers mois. En additionnant les transactions individuelles, l'initié a déjà cédé environ 252 000 actions, générant un produit brut cumulé de plusieurs centaines de milliers de dollars. Le nouveau lot de 3 900 actions suggère une poursuite de la tendance à la vente.

Aucune donnée financière, événement d'entreprise ou commentaire explicatif n'accompagne le dépôt ; le formulaire 144 signale uniquement une possible cession. Les investisseurs considèrent généralement une vente persistante par les initiés — surtout à cette échelle — comme un indicateur de sentiment baissier, bien que les pourcentages absolus restent faibles par rapport au total des actions en circulation.

Shimmick Corp. (SHIM) – Form 144 Einreichung offenbart, dass Insider Mitchell B. Goldsteen plant, bis zu 3.900 Stammaktien über TD Securities etwa am 24. Juli 2025 zu verkaufen. Basierend auf dem zuletzt in der Einreichung verwendeten Marktpreis würde der Verkauf rund 8,1 Tausend US-Dollar einbringen. Die vorgeschlagenen Aktien entsprechen weniger als 0,01 % der insgesamt 34,36 Millionen ausstehenden Aktien des Unternehmens.

Die Mitteilung listet zudem eine umfangreiche Reihe vorheriger Verkäufe durch Goldsteen am offenen Markt in den letzten drei Monaten auf. Addiert man die einzelnen Transaktionen, hat der Insider bereits etwa 252.000 Aktien veräußert und dabei kumulierte Bruttoerlöse in mehreren hunderttausend Dollar erzielt. Die neue Tranche von 3.900 Aktien deutet auf eine Fortsetzung des Verkaufsdrucks hin.

Finanzielle Leistungsdaten, Unternehmensereignisse oder erläuternde Bemerkungen sind der Einreichung nicht beigefügt; das Form 144 signalisiert lediglich eine potenzielle Veräußerung. Investoren werten anhaltende Insiderverkäufe – insbesondere in diesem Umfang – typischerweise als bärisches Sentiment-Signal, obwohl die absoluten Prozentsätze im Verhältnis zu den ausstehenden Aktien gering bleiben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
CLACKSON TIMOTHY P

(Last) (First) (Middle)
C/O ELEVATION ONCOLOGY, INC.
101 FEDERAL STREET, SUITE 1900

(Street)
BOSTON MA 02110

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Elevation Oncology, Inc. [ ELEV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/23/2025 U 47,330(1)(2) D $0.36 0 I The Timothy P. Clackson Irrevocable GST Trust of 2020
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $1.31 07/23/2025 D 15,619 (3) 06/16/2032 Common Stock 15,619 $0 0 D
Stock Option (Right to Buy) $1.47 07/23/2025 D 31,238 (3) 06/15/2033 Common Stock 31,238 $0 0 D
Stock Option (Right to Buy) $3.35 07/23/2025 D 35,000 (3) 06/12/2034 Common Stock 35,000 $0 0 D
Stock Option (Right to Buy) $0.3051 07/23/2025 D 35,000 (3) 06/04/2035 Common Stock 35,000 $0 0 D
Explanation of Responses:
1. Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of June 8, 2025, by and among Elevation Oncology, Inc. (the "Issuer"), Concentra Biosciences, LLC ("Parent") and Concentra Merger Sub VI, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). On July 23, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a "Share") for an offer price of (i) $0.36 per Share in cash (the "Cash Amount"), and (ii) one non-transferable contractual contingent value right (each, a "CVR"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the "CVR Agreement"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the "Offer Price"). [continues to Footnote 2]
2. [continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price.
3. As of immediately prior to and conditioned upon the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an "Option") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding, it was cancelled for no consideration.
/s/ Robert Yang, Attorney-in-Fact 07/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Shimmick's (SHIM) latest Form 144 reveal?

Insider Mitchell B. Goldsteen intends to sell up to 3,900 common shares on or after 24 Jul 2025.

How many Shimmick shares has the insider already sold in the past 3 months?

The filing lists about 252,000 shares sold from late Apr 2025 to 23 Jul 2025.

What percentage of Shimmick’s shares does the new 3,900-share sale represent?

Less than 0.01 % of the company’s 34.36 m shares outstanding.

Who is the broker handling the proposed sale?

TD Securities (USA) LLC, 125 Park Ave., New York, NY 10017.

On which exchange will the shares be sold?

The notice cites the NASDAQ as the intended marketplace.
Elevation Oncolo

NASDAQ:ELEV

ELEV Rankings

ELEV Latest News

ELEV Latest SEC Filings

ELEV Stock Data

21.63M
53.04M
0.31%
67.77%
14.45%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON